Aberdeen Group’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.7M Buy
104,307
+15,223
+17% +$2.73M 0.03% 431
2025
Q1
$15M Sell
89,084
-345,097
-79% -$58.2M 0.03% 463
2024
Q4
$65.7M Sell
434,181
-27,706
-6% -$4.19M 0.12% 172
2024
Q3
$71.5M Buy
461,887
+13,938
+3% +$2.16M 0.13% 165
2024
Q2
$61.3M Buy
447,949
+19,496
+5% +$2.67M 0.12% 178
2024
Q1
$57M Buy
428,453
+27,109
+7% +$3.61M 0.11% 194
2023
Q4
$55.3M Buy
401,344
+46,288
+13% +$6.38M 0.12% 194
2023
Q3
$43.3M Buy
355,056
+25,495
+8% +$3.11M 0.11% 175
2023
Q2
$46.3M Buy
329,561
+23,488
+8% +$3.3M 0.11% 180
2023
Q1
$43.3M Buy
306,073
+50,810
+20% +$7.19M 0.11% 190
2022
Q4
$39.9M Buy
255,263
+98,199
+63% +$15.4M 0.11% 205
2022
Q3
$19.3M Buy
157,064
+76,467
+95% +$9.38M 0.06% 322
2022
Q2
$10.8M Buy
80,597
+10,529
+15% +$1.41M 0.03% 405
2022
Q1
$9.75M Sell
70,068
-8,514
-11% -$1.18M 0.02% 449
2021
Q4
$13.6M Sell
78,582
-6,199
-7% -$1.07M 0.03% 428
2021
Q3
$12.4M Buy
84,781
+4,893
+6% +$716K 0.03% 455
2021
Q2
$10.5M Sell
79,888
-2,969
-4% -$392K 0.02% 488
2021
Q1
$10.6M Buy
82,857
+15,845
+24% +$2.03M 0.02% 482
2020
Q4
$7.99M Buy
67,012
+6,548
+11% +$780K 0.02% 509
2020
Q3
$6.92M Sell
60,464
-6,712
-10% -$769K 0.02% 496
2020
Q2
$7.66M Sell
67,176
-4,414
-6% -$503K 0.02% 466
2020
Q1
$5.75M Sell
71,590
-3,319
-4% -$267K 0.02% 496
2019
Q4
$8M Sell
74,909
-1,896
-2% -$202K 0.02% 504
2019
Q3
$8.22M Sell
76,805
-1,846
-2% -$198K 0.02% 487
2019
Q2
$8.01M Sell
78,651
-1,190
-1% -$121K 0.02% 557
2019
Q1
$7.18M Buy
79,841
+20,435
+34% +$1.84M 0.02% 562
2018
Q4
$4.9M Sell
59,406
-395
-0.7% -$32.6K 0.01% 571
2018
Q3
$6.45M Buy
59,801
+3,435
+6% +$371K 0.01% 573
2018
Q2
$6.2M Buy
56,366
+7,909
+16% +$870K 0.01% 564
2018
Q1
$4.86M Sell
48,457
-7,319
-13% -$734K 0.01% 550
2017
Q4
$5.49M Sell
55,776
-86,449
-61% -$8.51M 0.01% 541
2017
Q3
$13.3M Buy
+142,225
New +$13.3M 0.02% 412